Yourgene Health PLC Confirmation of Results Date (7807H)
06 August 2021 - 4:00PM
UK Regulatory
TIDMYGEN
RNS Number : 7807H
Yourgene Health PLC
06 August 2021
Yourgene Health plc
("Yourgene" or the "Group" or the "Company")
Confirmation of Results Date
Analyst and Investor Presentations
Manchester, UK 6 August 2021: Yourgene (AIM: YGEN), a leading
international molecular diagnostic group, confirms that the full
year results for the year ended 31 March 2021 will be announced on
Wednesday 11 August 2021.
Analyst presentation
A briefing open to analysts will take place remotely via video
conference call on Wednesday 11 August 2021 at 9.30am. To register
and for more details of this call please contact Walbrook PR on
yourgene@walbrookpr.com
Investor presentation
A live presentation via the Investor Meet Company will be
delivered by Lyn Rees CEO and Barry Hextall CFO on Thursday 12
August 2021 at 2:00pm BST. The presentation is open to all existing
and potential shareholders. Questions can be submitted pre-event
via your Investor Meet Company dashboard up until 9am the day
before the meeting or at any time during the live presentation.
Investors can sign up to Investor Meet Company for free and add
to meet Yourgene Health PLC via:
https://www.investormeetcompany.com/yourgene-health-plc/register-investor
Investors who already follow Yourgene Health PLC on the Investor
Meet Company platform will automatically be invited.
Yourgene Health plc Tel: +44 (0)161 669 8122
Lyn Rees, Chief Executive Officer investors@yourgene-health.com
Barry Hextall, Chief Financial Officer
Joanne Cross, Director of Marketing
Cairn Financial Advisers LLP (NOMAD) Tel: +44 (0)20 7213 0880
Liam Murray / James Caithie / Ludovico
Lazzaretti
Singer Capital Markets (Joint Corporate Tel: +44 (0)20 7496 3000
Broker)
Aubrey Powell / Tom Salvesen / George
Tzimas
Stifel Nicolaus Europe Limited (Joint Tel: +44 (0)20 7710 7600
Corporate Broker)
Nicholas Moore / Matthew Blawat / Ben
Maddison
Walbrook PR Ltd (Media and Investor Tel: +44 (0)20 7933 8780 or yourgene@walbrookpr.com
Relations)
Paul McManus / Lianne Cawthorne Mob: 07980 541 893 / Mob: 07584 391 303
About Yourgene Health plc
Yourgene Health is an international molecular diagnostics group
which develops and commercialises genomic services and
technologies. The group works in partnership with global leaders in
DNA technology to advance diagnostic science.
Yourgene primarily develops, manufactures, and commercialises
simple and accurate molecular diagnostic solutions, for
reproductive health, precision medicine and infectious diseases.
The Group's flagship in vitro diagnostic products include
non-invasive prenatal tests (NIPT) for Down's Syndrome and other
genetic disorders, Cystic Fibrosis screening tests, invasive rapid
aneuploidy tests and DPYD genotyping.
Yourgene has a range of innovative DNA sample preparation
platforms, powered by Ranger(R) Technology, the Yourgene
LightBench(R) and Yourgene QS250, ideal for cell-free DNA
applications in NIPT and oncology including liquid biopsy.
Yourgene Genomic Services is a global laboratory service network
equipped to be a full life-cycle partner for clinical, research and
pharmaceutical organisations to support partners at the
preclinical, clinical, and post-market stages to develop,
manufacture, obtain regulatory approval and commercialise new
products and services. In addition, Yourgene Genomic Services
offers an NIPT and high throughput COVID testing service.
Yourgene Health is headquartered in Manchester, UK with
facilities in Taipei, Singapore, the US and Canada, and is listed
on the London Stock Exchange's AIM market under the ticker "YGEN".
Follow us on LinkedIn and Twitter .
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NORZZGGRMKNGMZZ
(END) Dow Jones Newswires
August 06, 2021 02:00 ET (06:00 GMT)
Yourgene Health (LSE:YGEN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Yourgene Health (LSE:YGEN)
Historical Stock Chart
From Apr 2023 to Apr 2024